Cargando…

Lifestyle Therapy for the Treatment of Youth with Type 2 Diabetes

Type 2 diabetes (T2D) in youth is a relatively novel condition facing paediatric health care providers. Few experimental trials exist to guide clinical management in this population. Supporting and prescribing modifiable lifestyle behaviours is cornerstone in the management of T2D in adults. Clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: McGavock, Jonathan, Dart, Allison, Wicklow, Brandy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232742/
https://www.ncbi.nlm.nih.gov/pubmed/25398207
http://dx.doi.org/10.1007/s11892-014-0568-z
_version_ 1782344628916191232
author McGavock, Jonathan
Dart, Allison
Wicklow, Brandy
author_facet McGavock, Jonathan
Dart, Allison
Wicklow, Brandy
author_sort McGavock, Jonathan
collection PubMed
description Type 2 diabetes (T2D) in youth is a relatively novel condition facing paediatric health care providers. Few experimental trials exist to guide clinical management in this population. Supporting and prescribing modifiable lifestyle behaviours is cornerstone in the management of T2D in adults. Clinical trials in obese adolescents suggest that intensive lifestyle interventions that include both dietary changes and increased physical activity elicit clinically meaningful reductions in weight and improve cardiovascular risk profiles. Observational studies in youth with T2D suggest that better diet quality and increased physical activity are associated with better metabolic control; however, the limited experimental data available does not support these observations. Trials evaluating lifestyle monotherapy for the treatment of hyperglycaemia in youth with T2D do not exist, and the only study evaluating combined lifestyle and pharmacologic therapy did not show additional benefit over pharmacologic treatment with metformin alone. Physiological and psychosocial differences between youth and adults with T2D likely contribute to the differences in the effectiveness of lifestyle therapy for improving glycaemic control. The current review describes these topics in detail and provides recommendations for paediatric health care providers for the promotion of lifestyle therapy for the management of hyperglycaemia and cardiovascular risk factors for youth with T2DM.
format Online
Article
Text
id pubmed-4232742
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-42327422014-11-18 Lifestyle Therapy for the Treatment of Youth with Type 2 Diabetes McGavock, Jonathan Dart, Allison Wicklow, Brandy Curr Diab Rep Pediatric Type 2 Diabetes (PS Zeitler, Section Editor) Type 2 diabetes (T2D) in youth is a relatively novel condition facing paediatric health care providers. Few experimental trials exist to guide clinical management in this population. Supporting and prescribing modifiable lifestyle behaviours is cornerstone in the management of T2D in adults. Clinical trials in obese adolescents suggest that intensive lifestyle interventions that include both dietary changes and increased physical activity elicit clinically meaningful reductions in weight and improve cardiovascular risk profiles. Observational studies in youth with T2D suggest that better diet quality and increased physical activity are associated with better metabolic control; however, the limited experimental data available does not support these observations. Trials evaluating lifestyle monotherapy for the treatment of hyperglycaemia in youth with T2D do not exist, and the only study evaluating combined lifestyle and pharmacologic therapy did not show additional benefit over pharmacologic treatment with metformin alone. Physiological and psychosocial differences between youth and adults with T2D likely contribute to the differences in the effectiveness of lifestyle therapy for improving glycaemic control. The current review describes these topics in detail and provides recommendations for paediatric health care providers for the promotion of lifestyle therapy for the management of hyperglycaemia and cardiovascular risk factors for youth with T2DM. Springer US 2014-11-11 2015 /pmc/articles/PMC4232742/ /pubmed/25398207 http://dx.doi.org/10.1007/s11892-014-0568-z Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Pediatric Type 2 Diabetes (PS Zeitler, Section Editor)
McGavock, Jonathan
Dart, Allison
Wicklow, Brandy
Lifestyle Therapy for the Treatment of Youth with Type 2 Diabetes
title Lifestyle Therapy for the Treatment of Youth with Type 2 Diabetes
title_full Lifestyle Therapy for the Treatment of Youth with Type 2 Diabetes
title_fullStr Lifestyle Therapy for the Treatment of Youth with Type 2 Diabetes
title_full_unstemmed Lifestyle Therapy for the Treatment of Youth with Type 2 Diabetes
title_short Lifestyle Therapy for the Treatment of Youth with Type 2 Diabetes
title_sort lifestyle therapy for the treatment of youth with type 2 diabetes
topic Pediatric Type 2 Diabetes (PS Zeitler, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232742/
https://www.ncbi.nlm.nih.gov/pubmed/25398207
http://dx.doi.org/10.1007/s11892-014-0568-z
work_keys_str_mv AT mcgavockjonathan lifestyletherapyforthetreatmentofyouthwithtype2diabetes
AT dartallison lifestyletherapyforthetreatmentofyouthwithtype2diabetes
AT wicklowbrandy lifestyletherapyforthetreatmentofyouthwithtype2diabetes